Physical and functional interaction between the ID1 and p65 for activation of NF-κB

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 3, 2012, Pages

  Peng, Xiao ^a   Wang, Yuna ^a   Kolli, Swapna ^b   Deng, Junpeng ^b   Li, Li ^a   Wang, Zhixin ^c   Usha Raj, J ^c   Gou, Deming ^a  

^a SHENZHEN UNIVERSITY   (China)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Helix loop helix domain; Transcriptional activation domain

Indexed keywords

HELIX LOOP HELIX PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; INHIBITOR OF DIFFERENTIATION 1; LUCIFERASE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION DOMAINS AND MOTIFS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864517982     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00365.2011     Document Type: Article

References (50)

1. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40, 2009.
2. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59, 1990.
3. Bentires-Alj M, Dejardin E, Viatour P, Van Lint C, Froesch B, Reed JC, Merville MP, Bours V. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Oncogene 20: 2805-2813, 2001.
4. Bhattacharya R, Kowalski J, Larson AR, Brock M, Alani RM. Id1 promotes tumor cell migration in nonsmall cell lung cancers. J Oncol 2010: 856105, 8, 2010.
5. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488, 1995.
6. Cheung HW, Ling MT, Tsao SW, Wong YC, Wang X. ID1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis 25: 881-887, 2004.
7. Deng J, Davies DR, Wisedchaisri G, Wu M, Hol WG, Mehlin C. An improved protocol for rapid freezing of protein samples for long-term storage. Acta Crystallogr D Biol Crystallogr 60: 203-204, 2004.
8. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ, Desprez PY. ID1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci USA 100: 13543-13548, 2003.
9. Forootan SS, Wong YC, Dodson A, Wang X, Lin K, Smith PH, Foster CS, Ke Y. Increased ID1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol 38: 1321-1329, 2007.
10. Gou D, Weng W, Su L, Chintagari NR, Wang ZX, Zhang HH, Gao L, Wang PC, Liu L. Annexin A2 interactions with Rab14 in alveolar type II cells. J Biol Chem 283: 13156-13164, 2008.
11. Gundersen K, Merlie JP. ID1 as a possible transcriptional mediator of muscle disuse atrophy. Proc Natl Acad Sci USA 91: 3647-3651, 1994.
12. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004.
13. Heckman CA, Mehew JW, Boxer LM. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 21: 3898-3908, 2002.
14. Hong SY, Yoon WH, Park JH, Kang SG, Ahn JH, Lee TH. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem 275: 18022-18028, 2000.
15. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, neogenin, ID1, and CDC25B genes in ESCC. Clin Cancer Res 7: 2213-2221, 2001.
16. Hui CM, Cheung PY, Ling MT, Tsao SW, Wang X, Wong YC, Cheung AL. ID1 promotes proliferation of p53-deficient esophageal cancer cells. Int J Cancer 119: 508-514, 2006.
17. James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol 80: 5301-5307, 2006.
18. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
19. Kebebew E, Treseler PA, Duh QY, Clark OH. The helix-loop-helix transcription factor, ID1, is overexpressed in medullary thyroid cancer. Surgery 128: 952-957, 2000.
20. Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y, Kong G. ID1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 112: 287-296, 2008.
21. Lee YS, Yoon S, Yoon HJ, Lee K, Yoon HK, Lee JH, Song CW. Inhibitor of differentiation 1 (Id1) expression attenuates the degree of TiO2-induced cytotoxicity in H1299 non-small cell lung cancer cells. Toxicol Lett 189: 191-199, 2009.
22. Lernbecher T, Müller U, Wirth T. Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365: 767-770, 1993.
23. Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC, Cheung AL. ID1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 28: 2313-2320, 2007.
24. Li Y, Dunn L, Greggio E, Krumm B, Jackson GS, Cookson MR, Lewis PA, Deng J. The R1441C mutation alters the folding properties of the ROC domain of LRRK2. Biochim Biophys Acta 1792: 1194-1197, 2009.
25. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY. A role for ID1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60: 1332-1340, 2000.
26. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. ID1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 22: 4498-4508, 2003.
27. Ling MT, Wang X, Zhang X, Wong YC. The multiple roles of ID1 in cancer progression. Differentiation 74: 481-487, 2006.
28. Liu Y, Denlinger CE, Rundall BK, Smith PW, Jones DR. Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281: 31359-31368, 2006.
29. Maruyama H, Kleeff J, Wildi S, Friess H, Büchler MW, Israel MA, Korc M. ID1 and ID2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 155: 815-822, 1999.
30. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905, 2000.
31. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067-1070, 2001.
32. O'Shea JM, Perkins ND. Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 36: 603-608, 2008.
33. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC. Over expression of ID1 in prostate cancer. J Urol 167: 2598-2602, 2002.
34. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW, Wong YC. ID1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis 23: 721-725, 2002.
35. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5: 603-614, 2005.
36. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol 21: 524-533, 2001.
37. Rothschild SI, Kappeler A, Ratschiller D, Betticher DC, Tschan MP, Gugger M, Gautschi O. The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. Lung Cancer 71: 306-311, 2011.
38. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of ID1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 61: 5703-5706, 2001.
39. Schindl M, Schoppmann SF, Ströbel T, Heinzl H, Leisser C, Horvat R, Birner P. Level of ID1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 9: 779-785, 2003.
40. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P. Overexpression of ID1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer 104: 677-682, 2003.
41. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31: 3381-3385, 2003.
42. Tanaka H, Hoshikawa Y, Oh-hara T, Koike S, Naito M, Noda T, Arai H, Tsuruo T, Fujita N. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation. Mol Cancer Res 7:557-69, 2009.
43. Tang R, Hirsch P, Fava F, Lapusan S, Marzac C, Teyssandier I, Pardo J, Marie JP, Legrand O. High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. Blood 114: 2993-3000, 2009.
44. Wang P, Chintagari NR, Gou D, Su L, Liu L. Physical and functional interactions of SNAP-23 with annexin A2. Am J Respir Cell Mol Biol 37: 467-476, 2007.
45. Wang X, Xu K, Ling MT, Wong YC, Feng HC, Nicholls J, Tsao SW. Evidence of increased ID1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells. Mol Carcinog 35: 42-49, 2002.
46. Wong YC, Wang X, Ling MT. ID1 expression and cell survival. Apoptosis 9: 279-289, 2004.
47. Yang Y, Liou HC, Sun XH. Id1 potentiates NF-kappaB activation upon T cell receptor signaling. J Biol Chem 281: 34989-34996, 2006.
48. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004.
49. Zhang X, Ling MT, Wang Q, Lau CK, Leung SC, Lee TK, Cheung AL, Wong YC, Wang X. Identification of a novel inhibitor of differentiation-1 (ID1) binding partner, caveolin-1, and its role in epithelialmesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem 282: 33284-33294, 2007.
50. Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene 20: 8317-8325, 2001.